Table 1. Baseline characteristics of controls and cases.
Control (Group-2) No. 19 | Case (Group-1) No. 19 | P-value | |
Demographic data and comorbidities | |||
Age (years) (SD) | 54.36 (12.14) | 59.74 (13.82) | 0.33 |
Gender: Male (%) | 10 (52.63) | 14 (73.68) | 0.18 |
Smoking History (%) | 4 (21.05) | 4 (21.05) | 0.65 |
Body mass index >30 (%) | 11 (57.89) | 10 (52.63) | 0.74 |
History of diabetes (%) | 10 (52.63) | 11 (57.89) | 0.74 |
History of hypertension (%) | 10 (52.63) | 11 (57.89) | 0.74 |
History of chronic heart disease (%) | 5 (26.32) | 5 (26.32) | 0.99 |
History of renal impairment (%) | 3 (15.79) | 2 (10.53) | 0.63 |
History of chronic obstructive pulmonary disease (%) | 1 (5.26) | 0 (0) | 0.31 |
History of Asthma (%) | 4 (21.05) | 3 (15.79) | 0.68 |
History of active malignancy (%) | 1 (5.26) | 3 (15.79) | 0.29 |
Inflammatory Biomarker Characteristics | |||
ESR (SD) | 69.48 (36.33) | 82.21 (40.92) | 0.24 |
CRP (IQ) | 7.2 (4.9-12.7) | 12.45 (5.92-16.85) | 0.23 |
Procalcitonin (IQ) | 0.15 (0.11-0.58) | 0.27 (0.09-0.43) | 0.78 |
D-dimer (IQ) | 1.24 (0.63-2.36) | 2.00 (0.78-7.88) | 0.21 |
LDH (SD) | 363 (301-565) | 480 (348-666) | 0.22 |
Ferritin (IQ) | 535 (262-1345) | 711 (263-1407) | 0.84 |
Lymphopenia at admission (%) | 8 (42.11) | 8 (42.11) | 0.10 |
Admission NLR >3.13(%) | 7 (36.84) | 15 (78.95) | 0.01 |
High Trop I during hospitalization (%) | 3 (16.67) | 2 (10.53) | 0.59 |
RDW > or equal to 14.1 (%) | 12 (63.16) | 14 (73.68) | 0.49 |
RDW value (IQ) | 14.7 (12.9-16.3) | 15.5 (13.7-17.3) | 0.14 |